Named for Jan Waldenström, a pioneer in treating blood cancers, the Waldenström Lifetime Achievement Award has been given by the IMS at each International Myeloma Workshop since 1989. This award is given to outstanding researchers in recognition to their long term contributions to the myeloma field.
Each member of the IMS Board, former awardees and each member of the Award Committee will nominate two candidates for the award. From the names provided, the Awards Committee will select four nominees and will collect the credentials of each candidate, which will then be circulated among the electors.
The members of the IMS Board, members of the Awards Committee, and prior awardees, will vote for one candidate from the shortlist of four names. The Awards Committee will then select the awardee taking in consideration the results of the vote
If you have any questions or require additional information regarding the Waldenstrom Award, please contact firstname.lastname@example.org.
The International Myeloma Society is a professional, scientific, and medical society established to bring together clinical and experimental scientists involved in the study of myeloma. The purpose of this society is to promote research, education, clinical studies (including diagnosis and treatment), workshops, conferences, and symposia on all aspects of multiple myeloma worldwide. The IMS is a membership organization comprised of basic research scientists, and clinical investigators in the field along with physicians and other healthcare practitioners.